<?xml version="1.0" encoding="UTF-8"?>
<p>Several diarylureas were described in the literature for their activities on CNS. Compound 
 <bold>52</bold> (
 <xref rid="antibiotics-10-00092-t004" ref-type="table">Table 4</xref>) was effective as antiepileptic in both maximal electroshock (MES) and subcutaneous pentylenetetrazole (scPTZ) seizure tests, showing ED
 <sub>50</sub> value of 28.5 mg/kg against MES induced seizures. Toxicological results revealed that no significant toxicity was detected after administration for 14 days (sub-acute toxicity study) in rats. It also exerted antidepressant activity in forced swim test (FST) and tail suspension test (TST) in mice [
 <xref rid="B99-antibiotics-10-00092" ref-type="bibr">99</xref>].
</p>
